[Asia Economy Reporter Geum Boryeong] Olix announced on the 25th that it has signed a GalNAc siRNA research and development supply contract worth 1,815,150,000 KRW with a Europe-based global pharmaceutical and bio company.



The contract amount corresponds to 161% of last year's sales. The contract period is until June 23, 2021.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing